Navigation Links
Bees help to beat MRSA bugs
Date:6/28/2010

Bees could have a key role to play in urgently-needed new treatments to fight the virulent MRSA bug, according to research led at the University of Strathclyde in Glasgow, Scotland.

The scientists found that a substance known as beeglue or propolis, originating from beehives in the Pacific region, was active against MRSA, which causes potentially fatal infections, particularly in hospital patients.

The bug was either the underlying cause or a contributory factor in more than 1,900 deaths between 1996 and 2008.

The research, published in Phytotherapy Research journal, is an example of the pioneering work of the Strathclyde Institute of Pharmacy and Biomedical Sciences in developing new medicines for illnesses and conditions including infectious diseases, cancer, heart disease, and schizophrenia. An 8 million fundraising campaign is underway for the Institute's new 36 million building, to expand and enhance its innovative research and education in medicine discovery, development and use.

Dr Vronique Seidel, a Lecturer in Natural Products Chemistry at the Institute, led the research. She said: "MRSA can have a devastating impact on people who contract it and on their families, often compounding illnesses they already have.

"One of the few available drugs to treat MRSA infections is an antibiotic called vancomycin. But new strains have been emerging which show limited susceptibility, or even resistance, to vancomycin.

"This means that there is a pressing need to discover and develop alternatives to current anti-MRSA drugs. We investigated propolis, as part of a programme aimed at discovering new antibiotics from natural sources, because bees use it as an antiseptic glue to seal gaps between honeycombs and preserve their hives from microbial contamination.

"Beeglue is also a natural remedy widely-used in folk medicine for a variety of ailments but little has been known until now about its capacity to target MRSA. Our results have been highly encouraging and we will be taking our research further to understand how active substances in propolis work and to seek the treatments which patients urgently require."

The Strathclyde researchers have been working in partnership with Nature's Laboratory in North Yorkshire, England, a world leader in propolis research and campaigner for deeper scientific understanding of natural medicines. They tested extracts of propolis on 15 MRSA strains obtained from the NHS and isolated two compounds, Propolin C and Propolin D, which showed good activity against all the MRSA strains tested.

The research is the first to report anti-MRSA activity in propolis originating from the Pacific region and the first to describe the anti-MRSA properties of Propolin C and Propolin D. These could possibly act as templates for the development of improved anti-MRSA agents.


'/>"/>

Contact: Paul Gallagher
paul.gallagher@strath.ac.uk
44-141-548-2370
University of Strathclyde
Source:Eurekalert

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... -- The research team of The Hong Kong Polytechnic ... by adopting ground breaking 3D fingerprint minutiae recovery and matching technology, ... accuracy for use in identification, crime investigation, immigration control, security of ... ... A research team led by Dr ...
Breaking Biology News(10 mins):
(Date:6/28/2017)... 2017 (PRWEB) , ... June ... ... of Siemens’ STAR-CCM+® software for multiphysics computational fluid dynamics (CFD) simulation and ... exploration and optimization. STAR-CCM+ version 12.04 introduces Design Manager, allowing users to ...
(Date:6/27/2017)... ... June 27, 2017 , ... Brain State Technologies, ... Kickstarter campaign on June 15th to fund production of the new B2v2 wearable ... original Kickstarter goal by more than 150% in a little over a week. ...
(Date:6/27/2017)... ... June 27, 2017 , ... DuPont ... gains exclusive rights to the ERS patent portfolio covering CRISPR-Cas genome editing technology ... the foundational intellectual property (IP) of the CRISPR-Cas technology from co-inventor and co-owner ...
(Date:6/26/2017)... ... , ... Two new members were elected to the University City Science Center’s ... President, J Nowak Strategy and Michele Masucci, Ph.D., Vice President for Research Administration at ... and Kenneth L. Kring, and re-election of David P. Holveck and Richard P. Jaffe, ...
Breaking Biology Technology: